Abstract
1 This study was designed to evaluate the antihypertensive effects of oral nicardipine in patients treated for up to 2 years. Patients commenced the study on a fixed dose of 30 mg nicardipine three times a day with the dose then being varied in frequency and amount to suit each patient's requirements, in the range of 30-120 mg nicardipine day-1. Appropriate concomitant antihypertensive medication could be added to the nicardipine dosage regimen as required.
2 Adverse experiences generally were not severe. Withdrawal occurred in 14 patients (10%) due to adverse experiences, but these withdrawals occurred with greatest frequency during the early part of the study. Indeed no patient withdrew for adverse experiences during the second year of study. Eleven patients (8%) withdrew for intercurrent diseases and 18 (13%) patients withdrew for various other non-drug-related reasons.
3 A sustained antihypertensive effect was found over the 2 years of study. Supine systolic and diastolic blood pressures decreased from a mean of 170/105 mm Hg at baseline to a mean of 145/87 mm Hg at 2 years. Similar reductions were seen throughout the 2 years of study. An average clinical success rate of 60% was seen throughout the study for nicardipine as monotherapy and only 24 (17%) patients received a concomitant antihypertensive medication.
4 A significant age effect on antihypertensive response to nicardipine was seen for supine diastolic blood pressure but not for supine systolic blood pressure. The older the patient the greater the decrease in supine diastolic blood pressure. This was a consistent result across the 2 years of study.
5 No unexpected or unusual results were seen in the range of laboratory tests conducted or in the serial ECGs taken.
Keywords: nicardipine, essential hypertension, long-term efficacy
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asplund J. Nicardipine hydrochloride in essential hypertension--a controlled study. Br J Clin Pharmacol. 1985;20 (Suppl 1):120S–124S. doi: 10.1111/j.1365-2125.1985.tb05153.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forette F., Bellet M., Henry J. F., Hervy M. P., Poyard-Salmeron C., Bouchacourt P., Guerret M. Effect of nicardipine in elderly hypertensive patients. Br J Clin Pharmacol. 1985;20 (Suppl 1):125S–129S. doi: 10.1111/j.1365-2125.1985.tb05154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. I., Hornung R. S., Sonecha T., Raftery E. B. The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise. J Hypertens. 1983 Jun;1(1):85–89. [PubMed] [Google Scholar]
- Kolloch R., Stumpe K. O., Overlack A. Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol. Br J Clin Pharmacol. 1985;20 (Suppl 1):130S–134S. doi: 10.1111/j.1365-2125.1985.tb05155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]